Abstract
A 53-year-old woman presented with painful swelling of the right forefoot presenting clinically as a metatarsal stress fracture. Radiographs showed destructive changes, and diagnostic imaging revealed an aggressive neoplasm. The lesion was biopsied, and the pathologic diagnosis was metastatic melanoma. A thorough physical examination and advanced imaging did not reveal a primary tumor. Ray resection was performed with en bloc resection of the neoplasm. The patient continues to receive long-term immune stimulation chemotherapy 34 months after the ray resection.
Topics

No keywords indexed for this article. Browse by subject →

References
32
[1]
Weide "Melanoma patients with unknown primary site or nodal recurrence after initial diagnosis have a favourable survival compared to those with synchronous lymph node metastasis and primary tumour" PLoS One (2013) 10.1371/journal.pone.0066953
[2]
Greene AJCC Cancer Staging Handbook, (2010)
[3]
[4]
Garbe "Primary cutaneous melanoma: prognostic classification of anatomic location" Cancer (1995) 10.1002/1097-0142(19950515)75:10<2492::aid-cncr2820751015>3.0.co;2-w
[5]
Lee "Improved survival for stage IV melanoma from an unknown primary site" J Clin Oncol (2009) 10.1200/jco.2008.18.9845
[6]
Egberts "Metastatic melanoma of unknown primary resembles the genotype of cutaneous melanomas" Ann Oncol (2014) 10.1093/annonc/mdt411
[7]
Walsh "Survival of patients with primary pedal melanoma" J Foot Ankle Surg (2003) 10.1016/s1067-2516(03)70028-3
[8]
Luke "Ott P: PD-1 pathway inhibitors: the next generation of immunotherapy for advanced melanoma" Oncotarget (2015) 10.18632/oncotarget.2980
[9]
Wong "Surgical treatment of lymph nodes with metastatic melanoma from unknown primary site" Arch Surg (1987) 10.1001/archsurg.1987.01400240026003
[10]
Schlagenhauff "Metastatic melanoma of unknown primary origin shows prognostic similarities to regional metastatic melanoma" Cancer (1997) 10.1002/(sici)1097-0142(19970701)80:1<60::aid-cncr8>3.0.co;2-j
[11]
Anbari "Melanoma of unknown primary site" Cancer (1997) 10.1002/(sici)1097-0142(19970501)79:9<1816::aid-cncr26>3.0.co;2-#
[12]
Metastatic melanomas of unknown primary show better prognosis than those of known primary: A systematic review and meta-analysis of observational studies

Jung Min Bae, Yoon Young Choi, Dae Suk Kim et al.

Journal of the American Academy of Dermatology 2015 10.1016/j.jaad.2014.09.029
[13]
Fortin "Malignant melanoma of the foot and ankle" J Bone Joint Surg Am (1995) 10.2106/00004623-199509000-00016
[14]
Garbe "Primary cutaneous melanoma: prognostic classification of anatomic location" Cancer (1995) 10.1002/1097-0142(19950515)75:10<2492::aid-cncr2820751015>3.0.co;2-w
[15]
Egberts "Metastatic melanoma of unknown primary resembles the genotype of cutaneous melanomas" Ann Oncol (2014) 10.1093/annonc/mdt411
[16]
Lee "Improved survival for stage IV melanoma from an unknown primary site" J Clin Oncol (2009) 10.1200/jco.2008.18.9845
[17]
Fortin "Malignant melanoma of the foot and ankle" J Bone Joint Surg Am (1995) 10.2106/00004623-199509000-00016
[18]
Van Beek "Treatment of regional metastatic melanoma of unknown primary origin" Cancers (Basel) (2015) 10.3390/cancers7030849
[19]
Day "A prognostic model for clinical stage I melanoma of the lower extremity: location on foot as independent risk factor for recurrent disease" Surgery (1981)
[20]
Barnes "Melanoma of the foot" J Bone Joint Surg Am (1994) 10.2106/00004623-199406000-00013
[21]
[22]
Greene AJCC Cancer Staging Handbook, (2010)
[23]
Weide "Melanoma patients with unknown primary site or nodal recurrence after initial diagnosis have a favourable survival compared to those with synchronous lymph node metastasis and primary tumour" PLoS One (2013) 10.1371/journal.pone.0066953
[24]
Barnes "Melanoma of the foot" J Bone Joint Surg Am (1994) 10.2106/00004623-199406000-00013
[25]
Van Beek "Treatment of regional metastatic melanoma of unknown primary origin" Cancers (Basel) (2015) 10.3390/cancers7030849
[26]
Wong "Surgical treatment of lymph nodes with metastatic melanoma from unknown primary site" Arch Surg (1987) 10.1001/archsurg.1987.01400240026003
[27]
Luke "Ott P: PD-1 pathway inhibitors: the next generation of immunotherapy for advanced melanoma" Oncotarget (2015) 10.18632/oncotarget.2980
[28]
Day "A prognostic model for clinical stage I melanoma of the lower extremity: location on foot as independent risk factor for recurrent disease" Surgery (1981)
[29]
Metastatic melanomas of unknown primary show better prognosis than those of known primary: A systematic review and meta-analysis of observational studies

Jung Min Bae, Yoon Young Choi, Dae Suk Kim et al.

Journal of the American Academy of Dermatology 2015 10.1016/j.jaad.2014.09.029
[30]
Walsh "Survival of patients with primary pedal melanoma" J Foot Ankle Surg (2003) 10.1016/s1067-2516(03)70028-3
[31]
Anbari "Melanoma of unknown primary site" Cancer (1997) 10.1002/(sici)1097-0142(19970501)79:9<1816::aid-cncr26>3.0.co;2-#
[32]
Schlagenhauff "Metastatic melanoma of unknown primary origin shows prognostic similarities to regional metastatic melanoma" Cancer (1997) 10.1002/(sici)1097-0142(19970701)80:1<60::aid-cncr8>3.0.co;2-j
Metrics
2
Citations
32
References
Details
Published
Jan 01, 2017
Vol/Issue
107(1)
Pages
90-94
Cite This Article
Gary Friend, Jeffrey Mitchell (2017). Metastatic Melanoma of a Metatarsal. Journal of the American Podiatric Medical Association, 107(1), 90-94. https://doi.org/10.7547/15-202